1. Derogatis LR, Morrow GR, Fetting JH, et al.The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249:751-757.
2.
2. Zabora J, Brintzenhofenszoc K, Curbow B, Hooker C, Piantadosi S.The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19-28.
3.
3. Fallowfield L, Ratcliffe D, Jenkins V, Saul J.Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 2001;84:1011-1015.
4.
4. Hopwood P, Stephens RJ.Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 2000;18:893-903.
5.
5. Walker LG, Walker MB, Sharp DM.The organisation of psychosocial support within palliative care. In: Lloyd-Williams M, ed. Psychosocial Issues in Palliative Care. Oxford, UK: Oxford University Press; 2003.
6.
6. Loge JH, Abrahamson AF, Ekeberg O, Hannisdal E, Kaasa S.Psychological distress after cancer cure: a survey of 459 Hodgkin’s disease survivors. Br J Cancer. 1997;76:791-796.
7.
7. Anderson J, Walker MB, Walker LG.Distress and concerns of the partners of patients with breast cancer who receive primary chemotherapy. Psychoncology. 2000;9:357.
8.
8. Paraskevaidis E, Kitchener HC, Walker LG.Doctor-patient communication and subsequent mental health in women with gynecological cancer. Psychooncology. 1993;2:195-200.
9.
9. Walker LG, Dawson AA, Pollet SM, Ratcliffe MA, Hamilton L.Hypnotherapy for chemotherapy side effects. Br J Clin Exp Hypn. 1988;5:79-82.
10.
10. Cameron CL, Cella D, Herndon JE, et al.Persistent symptoms among survivors of Hodgkin’s disease: an explanatory model based on classical conditioning. Health Psychol. 2001;20:71-75.
11.
11. Walker LG.Hypnosis and cancer. Am J Prev Psychiat Neurol. 1992;3:42-49.
12.
12. Walker LG, Anderson J.Testing complementary and alternative medicine within a research protocol. Eur J Cancer. 1999;35:1614-1618.
13.
13. Benson H, Greenwood MM, Klemchuk H.The relaxation response: psychophysiologic aspects and clinical applications. Int J Psychiatry Med. 1975;6:87-98.
14.
14. Walker LG, Walker MB, Heys SD, et al.The psychological, clinical and pathological effects of relaxation training and imagery during primary chemotherapy. Br J Cancer. 1999;80:262-268.
15.
15. Baider L, Uziely B, De Nour AK.Progressive muscle relaxation and guided imagery in cancer patients. Gen Hosp Psychiatry. 1994;16:340-347.
16.
16. Bridge LR, Benson P, Pietroni PC, Priest RG.Relaxation and imagery in the treatment of breast cancer. Br Med J. 1988;297: 1170-1172.
17.
17. Eremin O, Walker MB, Simpson E, et al.Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer: a controlled trial. Psycho-oncology. In press.
18.
18. Greer S, Morris T, Pettingale KW, Haybittle JL.Psychological response to breast cancer and 15-year outcome. Lancet. 1990; 335:49-50.
19.
19. Anderson J, Walker LG.Psychological factors and cancer progression: involvement of behavioural pathways. In: Lewis CE, O’Brien R, Barraclough J, eds. The Psychoimmunology of Cancer. 2nd ed.Oxford, UK: Oxford University Press; 2002.
20.
20. Ratcliffe MA, Dawson AA, Walker LG.Eysenck Personality Inventory L-scores in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Psychooncology. 1995;4:39-45.
21.
21. Walker LG.Hypnotherapeutic insights and interventions: a cancer odyssey. Contemporary Hypnosis. 2004;21:35-45.
22.
22. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM.Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet. 1999;354:1331-1336.
23.
23. Richardson JL, Shelton DR, Krailo M, Levine AM.The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol. 1990;8:356-364.
24.
24. Jorge RE, Robinson RG, Arndt S, Starkstein S.Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160:1823-1829.
